This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
07/06/15 - 10:12:55 AM ET (BATS BZX Real-time Price)
Div Yield: --
CPXX Day's Range
CPXX 52 Week Range
CPXX Business Summary
Celator Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops therapies to treat cancer.View CPXX key stats
Celator Pharmaceuticals Inc - CPXX - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Celator Pharmaceuticals Inc as a
Sell with a ratings score of E+.
Report Snippet: We rate CELATOR PHARMACEUTICALS INC (CPXX) a SELL. This is based on some significant below-par investment measures, which should drive this stock to significantly underperform the majority of stocks that we rate. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow and generally disappointing historical performance in the stock itself.